Nektar Therapeutics
OrganizationHeard in 2 episodes across 2 shows since Jun 2026
Nektar Therapeutics is an American biopharmaceutical company founded in 1990 and headquartered in San Francisco, California. It develops drug candidates using proprietary PEGylation and advanced polymer-conjugate technologies designed to improve characteristics such as drug retention and solubility, and has supplied technology to pharmaceutical companies.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 1 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
| Nov 2026 | 0 |
Email alert
Email me when Nektar Therapeutics comes up on a podcast
One email a week at most, with the new episodes that mention Nektar Therapeutics. Free, no account needed, unsubscribe in one click.
What experts have said about Nektar Therapeutics
1 statement · 1 positive
Nektar’s sharp pullback appears unjustified and may present an opportunity.
“Nektar, what has really changed? I don't know. I don't really get why the pullback was so dramatic, but I think it's an opportunity.”
Open the episode · 118 - End of Week Wrap up - Oct 9, 2026Listen at 23:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
2 episodes featuring Nektar Therapeutics, newest first